Search
Now showing items 1-1 of 1
MOLECULAR NEUROIMAGING IN ALZHEIMER'S DISEASE: TARGETING BUTYRYLCHOLINESTERASE (BCHE) FOR POSITRON EMISSION TOMOGRAPHY (PET) AND SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IMAGING OF THE BRAIN
(2019-08-23)
Currently, there are no effective means to definitively diagnose Alzheimer’s disease (AD) during life. Molecular imaging of β-amyloid (Aβ) or tau neurofibrillary tangle (NFT) pathology in the AD brain, though informative, ...